东北制药
(000597)
| 流通市值：67.08亿 | | | 总市值：67.92亿 |
| 流通股本：14.09亿 | | | 总股本：14.27亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 3,332,979,035.72 | 2,006,198,284.03 | 7,074,853,263.92 | 5,478,085,124.55 |
| 营业总成本 | 3,191,533,782.39 | 1,926,096,917.42 | 6,671,639,822.19 | 5,196,594,704.99 |
| 其他经营收益 | | | | |
| 营业利润 | 102,264,378.69 | 25,889,397.35 | 314,111,882.4 | 271,193,063.26 |
| 利润总额 | 99,672,070.25 | 28,129,411.97 | 305,263,043.5 | 239,829,759.55 |
| 净利润 | 63,804,739.28 | 16,363,791.07 | 217,828,151.01 | 161,044,610.95 |
| 每股收益 | | | | |
| 其他综合收益 | -1,499,967.65 | -740,119.67 | -1,008,512.83 | -506,469.98 |
| 综合收益总额 | 62,304,771.63 | 15,623,671.4 | 216,819,638.18 | 160,538,140.97 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 8,439,985,936.69 | 8,340,220,558.85 | 7,532,294,394.94 | 8,228,274,866.84 |
| 非流动资产: | | | | |
| 非流动资产合计 | 5,137,731,478.42 | 5,249,774,164.55 | 5,356,653,460.07 | 5,420,328,595.89 |
| 资产总计 | 13,577,717,415.11 | 13,589,994,723.4 | 12,888,947,855.01 | 13,648,603,462.73 |
| 流动负债: | | | | |
| 流动负债合计 | 7,388,082,611.43 | 7,253,178,428.32 | 6,563,780,918.84 | 7,381,657,133.54 |
| 非流动负债: | | | | |
| 非流动负债合计 | 537,198,297.68 | 652,034,402.2 | 655,908,490.46 | 669,806,056.8 |
| 负债合计 | 7,925,280,909.11 | 7,905,212,830.52 | 7,219,689,409.3 | 8,051,463,190.34 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,533,681,411.13 | 5,555,649,471.09 | 5,529,861,664.8 | 5,363,710,455.54 |
| 股东权益合计 | 5,652,436,506 | 5,684,781,892.88 | 5,669,258,445.71 | 5,597,140,272.39 |
| 负债和股东权益合计 | 13,577,717,415.11 | 13,589,994,723.4 | 12,888,947,855.01 | 13,648,603,462.73 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 3,203,645,440.24 | 1,369,096,011.55 | 7,350,689,141.82 | 5,444,506,411.6 |
| 经营活动现金流出小计 | 3,277,608,685.69 | 1,352,207,153.42 | 6,244,306,660.55 | 5,065,303,687.65 |
| 经营活动产生的现金流量净额 | -73,963,245.45 | 16,888,858.13 | 1,106,382,481.27 | 379,202,723.95 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 10,994,177.01 | 8,940,372.22 | 58,711,604.97 | 1,170,604.8 |
| 投资活动现金流出小计 | 268,193,040.96 | 255,076,797.49 | 148,078,225.26 | 75,590,908.34 |
| 投资活动产生的现金流量净额 | -257,198,863.95 | -246,136,425.27 | -89,366,620.29 | -74,420,303.54 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 3,656,700,000 | 1,157,850,000 | 6,513,727,000 | 9,351,477,799.16 |
| 筹资活动现金流出小计 | 3,402,756,465.75 | 915,989,633.32 | 6,752,676,934.1 | 9,284,124,381.48 |
| 筹资活动产生的现金流量净额 | 253,943,534.25 | 241,860,366.68 | -238,949,934.1 | 67,353,417.68 |
| 汇率变动对现金及现金等价物的影响 | -27,150,677.62 | -21,314,318.66 | -23,810,422.88 | -8,550,203.22 |
| 现金及现金等价物净增加额 | -104,369,252.77 | -8,701,519.12 | 754,255,504 | 363,585,634.87 |
| 期末现金及现金等价物余额 | 2,747,877,855.17 | 2,843,545,588.82 | 2,852,247,107.94 | 2,461,577,238.81 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -104,369,252.77 | - | 754,255,504 | - |